Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study

Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study

BackgroundType 2 diabetes mellitus (T2DM) is an independent risk factor for osteoporosis, increasing the risk of fractures and poor prognosis. Recent studies suggest that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may play a protective role in bone metabolism. However, limited evidence ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming Chen, Yiming Lyu, Jingwei Zhao, Xianwei Han, Tao Huang, Tongtao Yang, Yong Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Endocrinology
Subjects:
type 2 diabetes
osteoporosis
GLP-1 receptor agonists
electronic medical records
cohort study
bone metabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1586589/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items